// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























30 Abstracts

Transient Pseudohypoaldosteronism as a Complication of Infected Obstructive Uropathy in Infancy, a Case Series

Alexandra Rodrigues Da Costa - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Obstructive uropathy

N/A

Early Core Valve Stenosis Due to Extensive Calcification in a Patient with Dialysis-dependent Chronic Renal Failure

Rajesh K. Nair - Angioplasty Summit-TCTAP , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Obstructive uropathy

Parathyroid hormone

Sarcoidosis-related hypercalcemia, renal failure, and hypothyroidism :a case report

Mariana Garcia-Touza - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Obstructive uropathy

Levothyroxine

Cabergoline Induced Pneumocephalus: A Rare But Potentially Fatal Complication

Revital Gorodeski-Baskin - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Obstructive uropathy

Cabergoline

HIPPO/YAP PATHWAY IN OBSTRUCTIVE UROPATHY: A NOVEL CONTRIBUTOR AND PROMISING THERAPEUTIC TARGET

Erin Salter - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Obstructive uropathy

N/A

CISPLATIN NEPHROTOXICITY IN A PATIENT WITH CERVICAL CANCER WITH ACQUIRED TYPE 2 RENAL TUBULAR ACIDOSIS: REVIEW OF LITERATURE AND CASE REPORT

G. ALHAQAS - International Society of Nephrology (ISN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Obstructive uropathy

Norepinephrine bitartrate

POLYURIC ACUTE KIDNEY INJURY FROM NON-DILATED OBSTRUCTIVE UROPATHY COMPLICATING RECURRENT ABDOMINOPELVIC SARCOMA

M. Onuigbo - International Society of Nephrology (ISN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Obstructive uropathy

N/A

Severe Hypermagnesemia-Induced Ischemic Colitis in a Patient with AKI

RebeccaLevy - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obstructive uropathy

N/A

Erythropoietin Stimulating Agent (ESA)-Resistant Vitamin B6 Deficiency Anemia in a Pediatric Patient on Hemodialysis

SagarPatel - American Society of Nephrology (ASN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Obstructive uropathy

Erythropoietin

URINARY ANGIOTENSINOGEN LEVEL IS CORRELATED WITH SEVERITY OF HYDRONEPHROSIS, BLOOD PRESSURE, AND ALBUMINURIA IN PATIENTS WITH UNILATERAL CHRONIC OBSTRUCTIVE UROPATHY

orhan zdemir - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obstructive uropathy

N/A

RENAL INVOLVEMENT IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS

Allyson Egan - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Obstructive uropathy

N/A

CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS IN ADVANCED STAGES OF CHRONIC ALLOGRAFT NEPHROPATHY: IS IT BENEFICIAL

Ali ghafari moghadam - European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Obstructive uropathy

Mycophenolate mofetil

PREDICTORS OF EARLY RE-INTERVENTION AFTER URETERAL TUMORSTENT INSERTION FOR OBSTRUCTIVE UROPATHY

Alexander Gu - American Urological Association (AUA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Obstructive uropathy

N/A

ANNUAL RENAL ULTRASOUND IS ADEQUATE SURVEILLANCE TO SCREEN FOR NEW OBSTRUCTIVE UROPATHY IN ADULT PATIENTS WITH CONGENITAL ANOMALIES OF THE BLADDER

Madeline Cancian - American Urological Association (AUA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Obstructive uropathy

N/A

CYP24A1 Mutation Masking Malignancy Mediated Hypercalcemia

Cheng Cheng - Endocrine Society (ENDO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Obstructive uropathy

Parathyroid hormone

Congenital megalourethra: a rare form of obstructive uropathy

D. Atanassova - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Obstructive uropathy

N/A

The wolf finds unusual prey

Mithun Chakravorty - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Obstructive uropathy

N/A

Is the Well-Recognized Intravascular Tamm-Horsfall Protein Polyp a Misnomer? A Case Report from a Patient with Obstructive Uropathy and Hematuria

Suo Liye - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Obstructive uropathy

N/A

Transient Anuric AKI Secondary to Parkinson Disease

Karam Sabine - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Obstructive uropathy

furosemide GR

Renal Medullary Carcinoma Causing Obstructive Uropathy

Seneriz RamonA - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Obstructive uropathy

N/A

Copyright © 2026. QuantiNova All rights reserved